サウスカロライナにおける肺がんの臨床試験
サウスカロライナ内の拠点で、肺がんに関する19件の研究が参加者を募集しています。
サウスカロライナ内の都市
- Charleston11件の研究
- Greenville9件の研究
- Spartanburg7件の研究
- Greer7件の研究
- Anderson5件の研究
- Columbia4件の研究
- Florence4件の研究
- Easley3件の研究
公式研究テキスト（英語）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Bon Secours Saint Francis Hospital, Charleston
- 他15件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- 他12件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
被験者募集中第3相
70歳以上 · 全性別 · 2026/10/01更新 · NCT06096844Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Prisma Health Cancer Institute - Easley, Easley
- Gibbs Cancer Center-Gaffney, Gaffney
- 他9件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Saint Joseph's Candler Health System ( Site 4010), Bluffton
- Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06312137A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Medical University of South Carolina, Florence
- Medical University of South Carolina Health Lancaster Medical Center, Lancaster
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/09/25更新 · NCT05920356A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Local Institution - 0608, Greenville
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07063745A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Medical University of South Carolina, Charleston
- Prisma Health Cancer Institute, Greenville
- Lexington Medical Center, West Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Health Education Approach to Lung Screening
- Medical University of South Carolina, Charleston
被験者募集中健康なボランティア歓迎
50歳〜80歳 · 全性別 · 2026/08/25更新 · NCT06070870Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- 他8件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996Prediction Augmented Screening Initiative
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
被験者募集中
50歳〜80歳 · 全性別 · 2026/06/26更新 · NCT06538636Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- AnMed Health Cancer Center, Anderson
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- 他9件
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- AnMed Health Cancer Center, Anderson
被験者募集中第2相
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- AnMed Health Cancer Center, Anderson
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Medical University of South Carolina, Charleston
- 他5件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- AnMed Health Cancer Center, Anderson
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Gibbs Cancer Center-Gaffney, Gaffney
- 他7件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- Ralph H. Johnson VA Health Care System, Charleston
被験者募集中観察研究
29歳〜85歳 · 全性別 · 2024/11/13更新 · NCT06426628ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。